$MRAM

FINCH LAWRENCE G sold $1.4M of MRAM (indirect holdings)

FINCH LAWRENCE G sold 41,961 indirectly-held shares of EVERSPIN TECHNOLOGIES INC. (MRAM) at $34.29 ($1.44M total) on 2026-05-11.

Original reporting
SEC EDGAR · FINCH LAWRENCE G
Published Jun 2, 2026, 9:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRAM
Bearish
medium confidence
Mentioned
$MRAM
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRAMBearishLow
01

Why it matters

The complete exit of a director may prompt short sellers and reduce confidence among investors.

02

Market read

Insider sell of $1.44M could pressure MRAM stock in the short term.

03

What to watch

No pre-arranged 10b5-1 plan; could indicate a discretionary decision.

Relevance 6/10Novelty 5/10Timing: post-filing today

Background

Form 4 filings disclose insider transactions; director-level sales are closely watched by traders.

Company-level read

Ticker impact

$MRAMBearishMedium confidence
Context

Director Finch Lawrence G sold 41,961 shares for $1.44M, reducing holdings to zero.

Expected impact

likely pressure as the market prices in the insider sale

Evidence & confidence

A director exiting completely can be viewed as a red flag, prompting short interest.

Market effects

Minimal impact on broader semiconductor sector.

U.S. market only.

Low global relevance.

Counterpoint

The sale may be unrelated to company fundamentals and driven by personal liquidity needs.

Key entities

  • EverSpin Technologies Inc.

    Issuer of the insider transaction.

  • Finch Lawrence G

    Director who sold the shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MUMed

Dow, S&P 500, Nasdaq Futures Slip As Trump Calls Iran’s Peace Proposal ‘Totally Unacceptable’ — MU, SNDK, MRAM, MLTX Stocks In Focus

U.S. stock futures fell Sunday night after President Trump rejected Iran's peace proposal, raising concerns about global energy supplies. Dow, S&P 500, and Nasdaq futures declined, while oil prices rose. Micron (MU) and Sandisk (SNDK) shares surged over 5% due to high demand for memory chips. Everspin (MRAM) and MoonLake (MLTX) also saw significant gains.

$MRAMMed

Everspin Reports Unaudited Second Quarter 2026 Financial Results

EVERSPIN TECHNOLOGIES INC. (MRAM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Everspin Reports Unaudited Second Quarter 2026 Financial Results Chandler, AZ, August 5, 2026 —Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and manufacturer of Magnetoresistive Random Access Memory (MRAM) persistent memory solutions, toda

$MRAMMed

Everspin stock surges 14% on MaxLinear AI server partnership

Everspin Technologies (NASDAQ:MRAM) shares rose 14% and MaxLinear (NYSE:MXL) gained 9% after both firms announced an MOU to evaluate next-generation memory architectures for AI servers. The plan combines Everspin’s persistent low-latency MRAM with MaxLinear’s storage compression, encryption and acceleration platform, targeting data-intensive workloads and market development for cloud and enterprise customers.

$NVDAMedAI 9/10

MarketBeat Week in Review – 05/18 - 05/22

Stocks rose into the week’s close, with NVIDIA (NVDA) results and forward guidance cited as evidence of tangible demand for AI infrastructure. Retail stocks showed a mixed consumer backdrop amid inflation concerns. U.S. markets were closed Monday for Memorial Day. The review also highlighted items including SpaceX’s public S-1 filing and a Phase 2 Alzheimer’s trial miss at Biogen (BIIB).